COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.

Hyposmia

Cohortias – Phase II trial of nasal spray therapy for Hyposmia

The trial is expected to enroll subjects at 20 clinical sites in the US and will assess CYR-064 for six months.

herpes zoster

Cohortias – When will the new vaccine to prevent herpes zoster be available in Argentina?

Shingrix shingles vaccine was 90% effective in preventing viral infection in adults over 50 years of age

Syndrome

Cohortias – ‘Incurable’ Fatal Syndrome May Finally Be Treated By New Drug

At the moment there’s no known cure for it, but scientists have now identified a potentially effective treatment

prostate

Cohortias – First data report from study of rare prostate cancer therapy

The trial assessed the efficacy and safety of BXCL701 along with pembrolizumab in SCNC patients.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.